EU Commission considering extending deferral period for organ, blood donors who leave area with WNV.
A request seeking an updated opinion on WNV containment measures has been made to the EU's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). "In light of an increase in WNV infections in humans in Portugal and potential similar situations in other European areas, the inclusion of these areas of a time-limited donor deferral pursuant to Directive 2004/33/EC and the introduction of testing for WNV may need to be reevaluated," the request said.
The "terms of reference" of the request stated:
"In light of recent evidence, the SCENIHR is requested to review the previous scientific opinion of the Scientific Committee on Medicinal Products and Medical Devices 'on the impact of arthropod borne diseases (WNV) on the safety of blood used for transfusion as well as organs used for transplantation in the European Community' as adopted on 16 October 2003 (SANCO/SCMPMD/2003/00025) in light of the new information.
The Committee is also asked to assess:
*The potential impact on the blood supply of introducing additional deferral criteria
*The impact on the use of tissues and cells used in therapy.
The SCENIHR is also requested to examine new scientific evidence and adopt an opinion on the impact of the risk of transmission of WNV through blood transfusion from infected donors beyond the current deferral period for 4 weeks."
The full report is available online at: www.europa.eu.int/comm/health/ph_risk/committees/04_scenihr/scenihr_questions_en.htm.
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 15, 2004|
|Previous Article:||Organ/tissue donation to be promoted on a float in the 2005 Rose Parade; theme is "Many Families, One Gift".|
|Next Article:||Organ donation drive begun in Malaysia.|